Pulmonx (LUNG) Operating Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Operating Expenses data on file, last reported at $30.4 million in Q3 2025.

• Operating Expenses for Q3 2025 came in at $30.4 million, up 4.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $93.4 million (down 22.01% YoY), and the FY2024 annual result was $119.7 million, up 6.23% from the prior year.
• Operating Expenses eased to $30.4 million in Q3 2025 per LUNG's latest filing, from $32.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $32.0 million in Q2 2025 and troughed at $19.1 million in Q1 2021.
• A 5-year average of $26.7 million and a median of $28.2 million in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2021 and 2024: Operating Expenses soared 73.16% in 2021, then rose 3.37% in 2024.
• A 5-year view of Operating Expenses shows it stood at $22.6 million in 2021, then rose by 14.12% to $25.8 million in 2022, then climbed by 9.72% to $28.3 million in 2023, then gained by 9.49% to $31.0 million in 2024, then declined by 1.81% to $30.4 million in 2025.
• Business Quant data shows LUNG's Operating Expenses at $30.4 million in Q3 2025, $32.0 million in Q2 2025, and $30.9 million in Q1 2025.